NMS·Healthcare·$521M·#76 / 520 in Healthcare
ASMB Assembly Biosciences, Inc.
68SOLID
CATEGORY BREAKDOWN
GROWTH100
QUALITY40
STABILITY74
VALUATION58
GOVERNANCE65
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+153.5%
100
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
17 months
61
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
1.3%
99
< 25% strong
Price / Sales
Market cap relative to trailing revenue
7.3x
58
< 3x strong
Rule of 40
Growth rate plus operating margin
137
100
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
28.4%
98
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+160.1%
0
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE ASMB WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when ASMB's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.